Use of Herbal Medicine in Internal Medicine Wards

This study has been completed.
Sponsor:
Information provided by:
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
NCT00564473
First received: November 27, 2007
Last updated: October 28, 2010
Last verified: October 2010
  Purpose

Herbs are physiologically active substances which can significantly affect the outcome of medical treatment, either by inhibiting or promoting drug disposition or through additive and synergistic effects when used in conjunction with conventional medications. Herb-drug interactions are potentially dangerous, and may be difficult to predict since regulation of the preparations is often lacking, and patients most often do not report the use of these products to their physicians. The risk for toxic effects and adverse interactions increases among high-risk groups, such as the elderly or patients with renal or hepatic disease. The purpose of this study is to study the prevalence of use of herbal medicine among patients hospitalized in the internal medicine department of an Israeli hospital, as well as examine the effect of herbal remedies on patient health, either beneficial or harmful. For this purpose, a questionnaire evaluating demographic data, medical history (both current and past), use of and attitudes towards herbal medicine will be administered to patients in the Department of Internal Medicine at the Shaare Zedek Medical Center in Israel. The Beck Depression Questionnaire will be used as well.


Condition Intervention
Herb-drug Interactions
Behavioral: questionnaire

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Use of Herbal Medicine Among Patients Hospitalized in a Department of Internal Medicine: A Cross-Sectional Survey

Resource links provided by NLM:


Further study details as provided by Shaare Zedek Medical Center:

Primary Outcome Measures:
  • * prevalence of use of herbal medicine among patients hospitalized in the Department of Internal Medicine at the Shaare Zedek Medical Center in Jerusalem, Israel. [ Time Frame: one year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • *prevalence of herb-drug interactions affecting treatment *rates of reporting use of herbal remedies *prevalence of toxic effects of herbal remedies *attitudes toward herbal medicine [ Time Frame: one year ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: June 2008
Study Completion Date: February 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
A
patients hospitalized in the Department of Internal Medicine of the Shaare Zedek Medical Center, Jerusalem, Israel.
Behavioral: questionnaire
  • questionnaire of demographic and medical data, use of and attituded toward herbal medicine.
  • Beck Depression Inventory-Second Edition (BDI-II)- Hebrew Translation

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients hospitalized in a department of internal medicine

Criteria

Inclusion Criteria:

  • Patients of either gender
  • Age 18 years and older

Exclusion Criteria:

  • Neurological deficit or other medical condition precluding responding to the questionnaires.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00564473

Locations
Israel
Shaare Zedek Medical Center
Jerusalem, Israel, 91031
Shaare Zedek Medical Center
Jerusalem, Israel
Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Principal Investigator: Noah Samuels, MD Shaare Zedek Medical Center
Principal Investigator: Shoshanna Zevin, MD Shaare Zedek Medical Center
  More Information

No publications provided

Responsible Party: Dr. Noah Samuels, Shaare Zedek Medical Center
ClinicalTrials.gov Identifier: NCT00564473     History of Changes
Other Study ID Numbers: HERB.INTMED.08
Study First Received: November 27, 2007
Last Updated: October 28, 2010
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Shaare Zedek Medical Center:
internal medicine
herbal medicine
prevalence
attitudes
herb-drug interaction

ClinicalTrials.gov processed this record on September 18, 2014